期刊文献+

血液指标与非创伤性股骨头坏死分期及病程的关系:多元Logistic回归分析

Relationship between blood indicators and course of nontraumatic osteonecrosis of femoral head in different stages:multiple logistic regression analysis
下载PDF
导出
摘要 背景:目前尚无关于血液实验室检查和非创伤性股骨头坏死分期及病程关系的文献,有必要进一步探讨分析以便更好地明确非创伤性股骨头坏死的影响因素。目的:分析血液实验室检查指标与非创伤性股骨头坏死国际骨循环研究会(ARCO)分期病程之间的关系,探讨非创伤性股骨头坏死病程的血液实验室指标影响因素。方法:采用回顾性研究的方法,从中国中医科学院望京医院数据库调取共2103例股骨头坏死患者的病历资料,根据纳入排除标准,最终纳入了1075例非创伤性股骨头坏死患者。收集患者的年龄、性别、体质量指数和血液实验室指标结果,血液实验室指标包含低密度脂蛋白、总胆固醇、三酰甘油、高密度脂蛋白、载脂蛋白β、载脂蛋白α1、尿酸、总蛋白定量、碱性磷酸酶、活化部分凝血活酶时间、凝血酶原时间、凝血酶原时间国际标准化比值、凝血酶原时间活动度、纤维蛋白原定量、凝血酶凝结时间、D-二聚体、总铁结合力、血小板计数。比较不同年龄段、不同ARCO分期患者的相关指标,并应用多元Logistic回归分析探讨股骨头坏死ARCO分期的影响因素。结果与结论:①青年组的总胆固醇、尿酸、凝血酶原时间、凝血酶原时间国际标准化比值、D-二聚体在ARCO分期组间比较差异有显著性意义(P<0.05),青年组ARCOⅡ期患者在总胆固醇水平上高于ARCOⅢ期患者(P<0.05),ARCOⅣ期的尿酸水平高于ARCOⅡ、Ⅲ期患者(P<0.05),ARCOⅡ、Ⅳ期的凝血酶原时间和凝血酶原时间国际标准化比值少于ARCOⅢ期患者(P<0.05),ARCOⅢ、Ⅳ期患者的D-二聚体高于ARCOⅡ患者(P<0.05);②中年组的高密度脂蛋白、凝血酶凝结时间、D-二聚体的ARCO分期组间比较差异有显著性意义(P<0.05),中年组ARCOⅣ期患者在高密度脂蛋白水平上高于ARCOⅡ、Ⅲ期患者(P<0.05),ARCOⅣ期凝血酶凝结时间短于ARCOⅢ期(P<0.05),ARCOⅣ期患者的D-二聚体水平高于ARCOⅡ、Ⅲ期患者(P<0.05);③老年组的尿酸、活化部分凝血活酶时间、D-二聚体、血小板计数组间比较差异有显著性意义(P<0.05),老年组ARCOⅣ期患者的尿酸水平高于ARCOⅡ、Ⅲ期患者(P<0.05),ARCOⅡ期患者的活化凝血酶原时间短于ARCOⅢ期(P<0.05),ARCOⅢ、Ⅳ期患者的D-二聚体水平高于ARCOⅡ期患者(P<0.05),ARCOⅣ期的血小板计数要低于ARCOⅢ期患者(P<0.05);④多元Logistic回归分析显示,总胆固醇和血小板计数是非创伤性股骨头坏死病程的保护性因素,D-二聚体、尿酸、超重、中青年年龄段可能是非创伤性股骨头坏死病程的危险因素;⑤提示不同ARCO分期患者的总胆固醇、高密度脂蛋白、尿酸、凝血酶原时间、凝血酶原时间国际标准化比值、D-二聚体存在统计学差异,总胆固醇、血小板计数可能是非创伤性股骨头坏死病程的保护性因素,D-二聚体、尿酸、超重、中青年年龄段可能是非创伤性股骨头坏死病程的危险因素。 BACKGROUND:Up to now,there is no literature on the relationship between blood laboratory tests and the course of nontraumatic osteonecrosis of femoral head in different stages.It is necessary to further explore and analyze so as to better clarify the influencing factors of nontraumatic osteonecrosis of femoral head.OBJECTIVE:To analyze the relationship between blood laboratory indicators and the course of nontraumatic osteonecrosis of the femoral head by the Association Research Circulation Osseous(ARCO),thus exploring the influencing factors of blood laboratory indicators on the course of nontraumatic osteonecrosis of the femoral head.METHODS:This study used a retrospective study design.A total of 2103 patients with osteonecrosis of the femoral head were retrieved from Wangjing Hospital of China Academy of Chinese Medical Sciences database,and 1075 patients with nontraumatic osteonecrosis of the femoral head were ultimately included based on inclusion and exclusion criteria.Patient age,gender,body mass index,and blood laboratory test results were collected.Blood laboratory tests included low-density lipoprotein,total cholesterol,triglycerides,high-density lipoprotein,apolipoproteinβ,apolipoproteinα1,uric acid,total protein quantitative,alkaline phosphatase,activated partial thromboplastin time,prothrombin time,prothrombin time International Normalized Ratio,prothrombin time activity,fibrinogen quantitative,coagulation time of thrombin,D-dimer,total iron binding capacity,and platelet count.The indicators of patients with different age groups and different ARCO stages were compared,and multiple Logistic regression analysis was applied to explore the influencing factors of ARCO stages in osteonecrosis of the femoral head.RESULTS AND CONCLUSION:(1)There were statistical differences in total cholesterol,uric acid,prothrombin time,prothrombin time International Normalized Ratio,and D-dimer among ARCO stages in the young group(P<0.05).Among young patients in ARCO stage II,total cholesterol levels were higher than those in ARCO stage III(P<0.05).Uric acid levels in ARCO stage IV were higher than those in ARCO stage II and III(P<0.05).Prothrombin time and prothrombin time International Normalized Ratio were shorter in ARCO stage IV and II than in ARCO stage III(P<0.05).D-dimer levels were higher in ARCO stage III and IV than in ARCO stage II(P<0.05).(2)There were statistically significant differences in high-density lipoprotein,coagulation time of thrombin,and D-dimer among ARCO stages in the middle-aged group(P<0.05).Among middle-aged patients in ARCO stage IV,high-density lipoprotein levels were higher than those in ARCO stages II and III(P<0.05).Coagulation time of thrombin was shorter in ARCO stage IV than in ARCO stage III(P<0.05).D-dimer levels were higher in ARCO stages IV than in ARCO stages II and III(P<0.05).(3)The uric acid,activated partial thromboplastin time,D-dimer,and platelet count in the elderly group showed statistically significant differences(P<0.05).The uric acid level in ARCO stage IV was higher than that in ARCO stage II and III patients in the elderly group(P<0.05),while the activated prothrombin time in ARCO stage II patients was shorter than that in ARCO stage III patients in the elderly group(P<0.05).The D-dimer level in ARCO stage III and IV patients was higher than that in ARCO stage II patients in the elderly group(P<0.05).The platelet count in ARCO stage IV was lower than that in ARCO stage III patients in the elderly group(P<0.05).(4)Multiple logistic regression analysis showed that total cholesterol and platelet count may be protective factors for course of nontraumatic osteonecrosis of the femoral head,while D-dimer,uric acid,overweight,and young and middle age may be risk factors for course of nontraumatic osteonecrosis of the femoral head.(5)It is indicated that total cholesterol,high-density lipoprotein,uric acid,prothrombin time,prothrombin time International Normalized Ratio,and D-dimer are statistically significant among patients with different ARCO stages.Total cholesterol and platelet count may be protective factors for the course of nontraumatic osteonecrosis of the femoral head,while D-dimer,uric acid,overweight,and middle-aged and young age groups may be hazard factors for the course of nontraumatic osteonecrosis of the femoral head.
作者 吴子轩 孙诗艺 张程 张光熠 杨统杰 何海军 Wu Zixuan;Sun Shiyi;Zhang Cheng;Zhang Guangyi;Yang Tongjie;He Haijun(Third Department of Orthopedics,Wangjing Hospital,China Academy of Chinese Medical Sciences,Beijing 100102,China;Beijing University of Chinese Medicine,Beijing 100029,China)
出处 《中国组织工程研究》 CAS 北大核心 2024年第36期5865-5871,共7页 Chinese Journal of Tissue Engineering Research
基金 中国中医科学院科技创新工程重大公关项目(CI2021A05406),项目负责人:何海军 国家自然科学基金资助项目(81873322),项目负责人:何海军。
关键词 非创伤性股骨头坏死 实验室检查 多元LOGISTIC回归分析 凝血功能 血脂 尿酸 nontraumatic osteonecrosis of the femoral head laboratory examination multiple logistic regression analysis blood coagulation function blood lipid uric acid
  • 相关文献

参考文献8

二级参考文献46

  • 1王岩,朱盛修,袁洁,杨立民.成人股骨头缺血坏死疗效评价(百分比)草案[J].骨与关节损伤杂志,1994,9(2):142-144. 被引量:106
  • 2Wortmann RL, Kelley WN. Gout and hyperuricemia. In: Ruddy S, Harris ED Jr, Sledge CB, editors. Kelley's Textbook of Rheu- matology[ M ]. 6th ed. Philadelphia: W. B. Saunders Company, 2001,1339-1376.
  • 3Oyama C, Takahashi T, Oyamada M, et al. Serum uric acid as an obesity-related indicator in early adolescence [ J ]. Tohoku J Exp Med, 2006,209(3 ) :257-262.
  • 4Choi HK, Atkinson K, Karlson EW, et al. Purine-rich foods, dairy and protein intake, and the risk of gout in men[J]. N Engl J Med, 2004,350( 11 ) :1093-1103.
  • 5Choi HK, Atkinson K, Karlson EW, et al. Alcohol intake and risk of incident gout in men : a prospective study [ J ]. Lancet, 2004, 363(9417) :1277-1281.
  • 6Choi HK, Curhan G. Beer, Liquor, and wine consumption and se- rum uric acid level: the third national health and nutrition exami- nation survey[J]. Arthritis Rheum, 2004,51 (6) :1023-1029.
  • 7Campion E, Glynn R, Delabry L. Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study [ J ]. Am J Med, 1987,82(3) :421-426.
  • 8Choi HK, Atkinson K, Karlson EW, et al. Obesity, weight change, hypertension, diureticuse, and risk of gout in men [ J ]. Arch Intern Med, 2005,165 (7) :742-748.
  • 9Gao X, Curhan G, Forman JP, et al. Vitamin C intake and serum uric acid concentration in men [ J ]. J Rheumatol, 2008,35 ( 9 ) : 1853-1858.
  • 10Choi HK, Curhan G. Coffee, tea, and caffeine consumption and serum uric acid level : the third national health and nutrition exami- nation survey [ J ]. Arthritis Rheum, 2007,56 ( 5 ) : 816 -821.

共引文献229

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部